CovAngelo:一种用于准确且可扩展药物发现的混合量子-经典计算平台
CovAngelo: A hybrid quantum-classical computing platform for accurate and scalable drug discovery
AI总结:
本文提出一种混合量子-经典计算平台,用于模拟复杂分子环境中的化学反应,通过量子信息增强的密度矩阵嵌入理论和量子化学求解器,实现高精度的强相关区域描述,并展示其在药物发现中的应用。
摘要:
我们提出了一种计算平台,用于建模复杂分子环境中化学反应,重点在于药物发现中的配体-蛋白质结合。该平台实现了我们新的量子-量子-经典(QM/QM/MM)多尺度嵌入模型,整合了分子动力学与量子信息增强的密度矩阵嵌入理论和量子化学求解器,包括显式溶剂。量子信息度量用于生成纠缠一致的轨道,使强相关区域的高精度描述成为可能。该框架支持多种计算后端,包括多CPU、NVIDIA多GPU架构和集成在CUDA-Q下的量子硬件(IQM、IonQ、IBM),并设计用于与未来容错量子系统兼容。新平台的能力通过模拟zanubrutinib与布鲁顿酪氨酸激酶的共价结合(通过迈克尔加成机制)来展示,计算了完整的反应能谱和能垒,相对于现有方法具有降低的计算成本。作为第二代抗癌药物,zanubrutinib为共价抑制剂发现提供了证明概念。通过我们方法提供的准确的原理反应能垒估计可以减少药物发现流程中的假阳性率和假阴性率。可扩展性通过GPU集群和基于云的CPU基础设施的基准测试得到验证。我们展示了与量子设备(最多20个量子位)的集成,以及容错量子计算的资源估计,表明可能的加速高达20倍。除了单个反应外,该平台还支持在化学度量空间中构建反应网络,促进配体筛选和系统探索反应路径。
英文摘要:
We present a computational platform for modeling chemical reactions in complex molecular environments, focused on ligand-protein binding in drug discovery. The platform implements our new quantum-in-quantum-in-classical (QM/QM/MM) multiscale embedding model that integrates molecular dynamics with a quantum-information-enhanced density matrix embedding theory and quantum chemistry solvers, including explicit solvent. Quantum-information metrics are utilized to generate entanglement-consistent orbitals, enabling a high-accuracy description of strongly correlated regions. The framework supports multiple computational backends, including multi-CPU, NVIDIA multi-GPU architectures, and quantum hardware (IQM, IonQ, IBM) integrated under CUDA-Q, and is designed for compatibility with future fault-tolerant quantum systems. The new platform's capabilities are demonstrated by modeling covalent docking of zanubrutinib to Bruton's tyrosine kinase via a Michael addition mechanism, computing the full reaction energy profiles and energy barriers at a reduced computational cost relative to existing methods. As a 2nd-generation anticancer agent, zanubrutinib serves as a proof of concept for covalent inhibitor discovery. Accurate first-principles reaction barrier estimations provided by our method can contribute to reducing false positive and negative rates in drug discovery pipelines. Scalability is validated through benchmarks on GPU clusters, cloud-based CPU infrastructures. We demonstrate integration with quantum devices (up to 20 qubits), alongside resource estimates for fault-tolerant quantum computing, indicating potential speedups of up to 20x. Beyond single reactions, the platform supports the construction of reaction networks in chemical metric space, facilitating ligand screening and systematic exploration of reactive pathways.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。